Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Palak Popat

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Indian Journal of Cancer|April 6, 2019
Bladder cancer demographics and outcome data from 2013 at a tertiary cancer hospital in IndiaGagan Prakash, Mahendra Pal, K Odaiyappan, et al.
Scientific Reports|August 1, 2025
Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancerKripa Bajaj, Sushmita Rath, Deep Vora, et al.
JCO Global Oncology|September 21, 2022
Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer With Brain Metastases: Real-World ExperiencePrabhat Bhargava, Narmadha Rathnasamy, Ramnath Shenoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2021
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled TrialVedang Murthy, Priyamvada Maitre, Sadhana Kannan, et al.
JCO Global Oncology|July 9, 2026
Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western IndiaKunal Jobanputra, Aditya Dhanawat, Gagan Prakash, et al.
Breast (Edinburgh, Scotland)|February 28, 2021
Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, IndiaJyoti Bajpai, Vijay Simha, T S Shylasree, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2025
Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled TrialSudeep Gupta, Nita Nair, Rohini W Hawaldar, et al.
Breast (Edinburgh, Scotland)|October 16, 2021
Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in IndiaJyoti Bajpai, Pradeep Ventrapati, Shalaka Joshi, et al.
JCO Global Oncology|April 23, 2025
Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant ChemotherapyMinit Shah, Sushmita Rath, Seema Gulia, et al.
Indian Journal of Cancer|August 28, 2018
Breast cancer in a tertiary cancer center in India - An audit, with outcome analysisNita Nair, Tanuja Shet, Vani Parmar, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Indian Journal of Cancer|April 6, 2019
Bladder cancer demographics and outcome data from 2013 at a tertiary cancer hospital in IndiaGagan Prakash, Mahendra Pal, K Odaiyappan, et al.
Scientific Reports|August 1, 2025
Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancerKripa Bajaj, Sushmita Rath, Deep Vora, et al.
JCO Global Oncology|September 21, 2022
Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer With Brain Metastases: Real-World ExperiencePrabhat Bhargava, Narmadha Rathnasamy, Ramnath Shenoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2021
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled TrialVedang Murthy, Priyamvada Maitre, Sadhana Kannan, et al.
JCO Global Oncology|July 9, 2026
Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western IndiaKunal Jobanputra, Aditya Dhanawat, Gagan Prakash, et al.
Breast (Edinburgh, Scotland)|February 28, 2021
Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, IndiaJyoti Bajpai, Vijay Simha, T S Shylasree, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2025
Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled TrialSudeep Gupta, Nita Nair, Rohini W Hawaldar, et al.
Breast (Edinburgh, Scotland)|October 16, 2021
Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in IndiaJyoti Bajpai, Pradeep Ventrapati, Shalaka Joshi, et al.
JCO Global Oncology|April 23, 2025
Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant ChemotherapyMinit Shah, Sushmita Rath, Seema Gulia, et al.
Indian Journal of Cancer|August 28, 2018
Breast cancer in a tertiary cancer center in India - An audit, with outcome analysisNita Nair, Tanuja Shet, Vani Parmar, et al.
Pageof 5